HAPPE Spine’s INTEGRATE-C Interbody Fusion System has been implanted in more than 1,000 patients, demonstrating clinical adoption of the HAPPE platform across more than 30 surgeon users and 40 facilities nationwide.
The company closed an oversubscribed bridge funding round earlier this year to support continued clinical validation of the HAPPE platform in the INTEGRATE-C Interbody Fusion System, and expansion of manufacturing capabilities to support commercial growth and future product offerings.
HAPPE Spine's INTEGRATE-C Interbody Fusion System has been implanted in more than 1,000 patients, demonstrating clinical adoption of the HAPPE platform across more than 30 surgeon users and 40 facilities nationwide.
The company closed an oversubscribed bridge funding round earlier this year to support continued clinical validation of the HAPPE...
HAPPE Spine’s INTEGRATE-C Interbody Fusion System has been implanted in more than 1,000 patients, demonstrating clinical adoption of the HAPPE platform across more than 30 surgeon users and 40 facilities nationwide.
The company closed an oversubscribed bridge funding round earlier this year to support continued clinical validation of the HAPPE platform in the INTEGRATE-C Interbody Fusion System, and expansion of manufacturing capabilities to support commercial growth and future product offerings.
Copy to clipboard 
